XETRA - Delayed Quote EUR
Biotest Aktiengesellschaft (BIO.DE)
At close: October 18 at 5:36 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
118,900.00
-2,700.00
-40,500.00
33,900.00
-16,700.00
--
Investing Cash Flow
-32,600.00
1,300.00
-37,000.00
-23,400.00
-14,600.00
--
Financing Cash Flow
-78,500.00
-6,800.00
89,600.00
22,600.00
42,000.00
--
Other Cash Adjustment Inside Change in Cash
--
-400.00
--
--
--
--
End Cash Position
66,100.00
108,100.00
116,600.00
104,400.00
71,300.00
--
Capital Expenditure
--
-33,400.00
-29,300.00
-18,200.00
-27,000.00
--
Issuance of Debt
--
10,100.00
100,000.00
25,100.00
50,000.00
--
Repayment of Debt
--
-12,000.00
--
--
-2,500.00
--
Free Cash Flow
85,500.00
-36,100.00
-69,800.00
15,700.00
-43,700.00
--
12/31/2019 - 11/19/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
T5O0.DE bioXXmed AG
3.1500
-9.74%
88Q.DE 4basebio PLC
16.20
0.00%
7V0.DE Darwin AG
31.40
+5.37%
PSH.DE Sernova Corp.
0.1748
-0.63%
AYJ.DE Valneva SE
2.6660
+4.71%
VX1.DE Vertex Pharmaceuticals Incorporated
447.30
-0.38%
HPHA.DE Heidelberg Pharma AG
2.6700
+4.71%
FYB.DE Formycon AG
52.90
+1.73%
BBZA.DE BB Biotech AG Ord
39.75
+0.38%
MDG1.DE Medigene AG
1.8720
+0.11%